Value proposition

A contract research organization (CRO) advancing the latest in drug development with leading sponsors, worldwide.

KCAS Bio is a top-tier contract research organization (CRO) that has 45 years of experience with both large pharma and biotech sponsors, providing comprehensive bioanalytical drug development services from early discovery through registration.

We have supported more than 300+ FDA approved drugs on the market, developed 5,000+ proprietary and non-proprietary assays to date, and undergone 18 FDA audits with no major findings.

Our presence in multiple locations throughout the US and Europe - and with a strategic alliance in Australia - allows us to serve sponsors globally with bioanalytical, biomarker, immunogenicity, cellular and molecular assay services along with clinical kitting and sample management.

With the expertise, capacity and flexibility sponsors require, we can fulfill our purpose, which is: to help accelerate the discovery and development of life-changing drugs smoothly, safely and sustainably.


Immunogenicity (ADA), Flow Cytometry, Vaccines, Method Dev + Transfer, Clinical PK/PD Kits, LC-MS/MS, GLP, GCP, non-GLP, ECL - MSD, ELISA, Biopharma LC-MS/MS, Receptor Occupancy, Luminex, Biomarkers, PD Biomarkers, PK / TK, and Hybrid LC-MS/MS